CLE for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia

NACompletedINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Barrett SyndromeBarrett's SyndromeBarrett's EsophagusBarrett EsophagusAdenocarcinoma
Interventions
DEVICE

Standard endoscopic evaluation

Treatment modalities can include endoscopic mucosal resection, radio-frequency ablation or photodynamic therapy

DEVICE

pCLE guided evaluation

Treatment modalities include endoscopic mucosal resection, radio-frequency ablation, or photodynamic therapy. probe-based Confocal Laser Endomicroscopy is used to decide on re-treatment or not, and to guide and evaluate the treatment during the same endoscopic procedure.

Trial Locations (6)

32224

Mayo Clinic, Jacksonville

60637

University of Chicago Hospital, Chicago

64128

Veterans Affairs Hospital, Kansas City

98115

University of Washington Medical Center, Seattle

Unknown

Centre Hospitalier Universitaire, Nantes

University College London Hospital, London

Sponsors
All Listed Sponsors
collaborator

Cellvizio Inc.

INDUSTRY

lead

Mauna Kea Technologies

INDUSTRY